Jiangsu Nuotai (Ao Nuo) Biopharmaceutical is a CDMO of peptides based in Unknown. Direct manufacturer. Key products include polypeptide drugs, active pharmaceutical ingredients (APIs).
Chinese GMP-compliant peptide manufacturer with high reactor capacity. 19.3% market share. $60M reve
Jiangsu Nuotai (Ao Nuo) Biopharmaceutical is listed as a CDMO in the peptide supply chain, serving Asia markets from Unknown. As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is based on publicly available information and cross-referenced against industry databases. This supplier has a lower confidence score — independent verification and third-party testing are strongly recommended before any transaction.